These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22186897)

  • 1. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
    Douglas AD; Williams AR; Illingworth JJ; Kamuyu G; Biswas S; Goodman AL; Wyllie DH; Crosnier C; Miura K; Wright GJ; Long CA; Osier FH; Marsh K; Turner AV; Hill AV; Draper SJ
    Nat Commun; 2011 Dec; 2():601. PubMed ID: 22186897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
    Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
    PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
    Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
    Front Immunol; 2021; 12():720550. PubMed ID: 34733274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
    Bustamante LY; Bartholdson SJ; Crosnier C; Campos MG; Wanaguru M; Nguon C; Kwiatkowski DP; Wright GJ; Rayner JC
    Vaccine; 2013 Jan; 31(2):373-9. PubMed ID: 23146673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
    Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
    Douglas AD; Williams AR; Knuepfer E; Illingworth JJ; Furze JM; Crosnier C; Choudhary P; Bustamante LY; Zakutansky SE; Awuah DK; Alanine DG; Theron M; Worth A; Shimkets R; Rayner JC; Holder AA; Wright GJ; Draper SJ
    J Immunol; 2014 Jan; 192(1):245-58. PubMed ID: 24293631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen.
    Knudsen AS; Walker MR; Agullet JP; Björnsson KH; Bassi MR; Barfod L
    Sci Rep; 2022 Feb; 12(1):3040. PubMed ID: 35197516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
    Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
    Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
    Mian SY; Somanathan A; Chaddha K; Pandey AK; Singh H; Krishna S; Chaturvedi N; Uchoi S; Shukla MM; Bharti PK; Singh N; Chauhan VS; Gaur D
    Infect Immun; 2022 Jan; 90(1):e0037721. PubMed ID: 34694918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
    Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
    Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
    Alanine DGW; Quinkert D; Kumarasingha R; Mehmood S; Donnellan FR; Minkah NK; Dadonaite B; Diouf A; Galaway F; Silk SE; Jamwal A; Marshall JM; Miura K; Foquet L; Elias SC; Labbé GM; Douglas AD; Jin J; Payne RO; Illingworth JJ; Pattinson DJ; Pulido D; Williams BG; de Jongh WA; Wright GJ; Kappe SHI; Robinson CV; Long CA; Crabb BS; Gilson PR; Higgins MK; Draper SJ
    Cell; 2019 Jun; 178(1):216-228.e21. PubMed ID: 31204103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.
    Patel SD; Ahouidi AD; Bei AK; Dieye TN; Mboup S; Harrison SC; Duraisingh MT
    J Infect Dis; 2013 Nov; 208(10):1679-87. PubMed ID: 23904294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.
    Douglas AD; Baldeviano GC; Lucas CM; Lugo-Roman LA; Crosnier C; Bartholdson SJ; Diouf A; Miura K; Lambert LE; Ventocilla JA; Leiva KP; Milne KH; Illingworth JJ; Spencer AJ; Hjerrild KA; Alanine DG; Turner AV; Moorhead JT; Edgel KA; Wu Y; Long CA; Wright GJ; Lescano AG; Draper SJ
    Cell Host Microbe; 2015 Jan; 17(1):130-9. PubMed ID: 25590760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
    Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
    PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.
    Healer J; Wong W; Thompson JK; He W; Birkinshaw RW; Miura K; Long CA; Soroka V; Søgaard TMM; Jørgensen T; de Jongh WA; Weir C; Svahn E; Czabotar PE; Tham WH; Mueller I; Barlow PN; Cowman AF
    Cell Microbiol; 2019 Jul; 21(7):e13030. PubMed ID: 30965383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes.
    Sakamoto H; Takeo S; Maier AG; Sattabongkot J; Cowman AF; Tsuboi T
    Vaccine; 2012 Mar; 30(11):1972-80. PubMed ID: 22248820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.